1-4 of 4
Aleksandr Lazaryan, MD, MPH, PhD
Close
Sort by
Journal Articles

Bortezomib for ITP: First Report of Successful Treatment of Refractory ITP In a Patient with Otherwise Asymptomatic Monoclonal Gammopathy

Aleksandr Lazaryan, MD, MPH, PhD, Alan E. Lichtin, MD, Keith R McCrae, M.D., Janice Reed, RN, Robert Dean, MD, Claudiu Cotta, MD, Frederic J. Reu, MD
Journal: Blood
Blood (2010) 116 (21): 4667.
https://doi.org/10.1182/blood.V116.21.4667.4667
Published: 2010
Journal Articles

Mature Results of MM011: A Phase I/II Trial of Lenalidomide, Liposomal Doxorubicin, Dexamethasone, and Vincristine, Followed by Lenalidomide Maintenance (DVd-R) for Relapsed or Refractory Multiple Myeloma

Aleksandr Lazaryan, MD, MPH, PhD, Rachid Baz, MD, Mohamad A Hussein, Jr, MD, Paul Elson, ScD, Beth Faiman, CNP, Becky Habecker, Mary Ann Karam, RN, Janice Reed, RN, Kimberly Hamilton, RN, Kellie Bruening, Gordan Srkalovic, MD, PhD, Steven Andresen, DO, Matt Kalaycio, MD, John William Sweetenham, MD, FRCP, Ronald Sobecks, MD, Robert Dean, MD, Robert Knight, MD, Jerome B. Zeldis, MD, PhD, Frederic J. Reu, MD
Journal: Blood
Blood (2010) 116 (21): 1967.
https://doi.org/10.1182/blood.V116.21.1967.1967
Published: 2010
Journal Articles

Adverse Factors in Clinical Outcomes of T-Cell Large Granular Lymphocyte Leukemia.

Nelli Bejanyan, MD, Aleksandr Lazaryan, MD, MPH, PhD, Michael Clemente, Matthew Howard, MD, Karl S. Theil, MD, Eric D. Hsi, MD, Thomas P. Loughran, Jr., MD, Alan Lichtin, MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1086.
https://doi.org/10.1182/blood.V114.22.1086.1086
Published: 2009
Journal Articles

Impact of MICA and Other Immunogenetic Polymorphisms On Clinical Presentation of T Cell Large Granular Lymphocyte Leukemia.

Aleksandr Lazaryan, MD, MPH, PhD, Nelli Bejanyan, MD, Aaron D. Viny, MD, MS, Medhat Askar, MD, PhD, Pearlie K Burnette, PhD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1094.
https://doi.org/10.1182/blood.V114.22.1094.1094
Published: 2009